June 6, 2023 ASCO Annual Meeting Join fellow oncology professionals at the 2023 ASCO Annual Meeting – a unique and unparalleled opportunity to connect with one o
May 31, 2023 CACNA1A Foundation to Contribute Data to C-Path’s RDCA-DAP, Accelerating Neurological Disease Research and Therapeutic Development TUCSON, Ariz., May 31, 2023 — Critical Path Institute (C-Path) announced today that the CACNA1A Foundation, a parent-led nonprof
May 31, 2023 C-Path’s Transplant Therapeutics Consortium’s Work Highlighted in Recent Publication in the American Journal of Transplantation C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in the American Journal of Transplan
May 25, 2023 C-Path Welcomes Red Nucleus Clinical C-Path is proud to welcome Red Nucleus Clinical as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consor
May 24, 2023 Improving the Design of Clinical Trials in T1D: Analysis of Data from the Trial Outcome Markers Initiative (TOMI) Collaboration With presentations from JDRF, TrialNet and the TOMI-T1D Collaboration The Trial Outcome Marker Initiative brings together data fro
May 4, 2023 Results of the 2022 global WHO online survey on diagnostic capacities and treatment practices for implantation (deep) mycoses Barbara Milani (WHO consultant), under the guidance of Daniel Argaw Dagne (WHO Department of Control of Neglected Tropical...
May 4, 2023 A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical...
May 3, 2023 Video: Brief TRxA Overview In this video, TRxA Executive Director Maaike Everts and Associate Director Michelle Morgan give viewers a short overview of the..
May 2, 2023 C-Path’s CDRC Meeting Highlights the Importance of Drug Repurposing The Critical Path Institute’s CURE Drug Repurposing Collaboratory and FDA hosted their annual meeting April 18-20 to bring toget
April 27, 2023 View Now | Clinical Outcome Assessments: Does one size fit all? Join C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform and its Rare Disease Clinical Outcome Assessment
